Ligand Pharmaceuticals Inc (LGND)
Other Income/Expenses (Net)
$137.03M
TTM · Period ending: · USD
LGND Other Income/Expenses (Net)
Latest reported$137.03Mperiod ending
Latest reported$137.03Mperiod ending
LGND TTM Other Income/Expenses (Net) (-$5.40M → $137.03M)
TTM Other Income/Expenses (Net)
High-resolution chart · PNG
LGND other income/expenses (net) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| 137,032,000 | |
| 84,098,000 | |
| 111,761,000 | |
| 45,458,000 | |
| -50,230,000 | |
| -99,299,000 | |
| 25,124,000 | |
| 75,142,000 | |
| 69,402,000 | |
| 120,846,000 | |
| 51,718,000 | |
| 75,017,000 | |
| 90,252,000 | |
| 85,097,000 | |
| 32,489,000 | |
| -31,025,000 | |
| -31,485,000 | |
| -43,922,000 | |
| -31,596,000 | |
| -19,676,000 | |
| -34,588,000 | |
| -1,131,000 | |
| -36,383,000 | |
| -26,539,000 | |
| -25,893,000 | |
| -60,810,000 | |
| -10,437,000 | |
| -102,379,000 | |
| -31,802,000 | |
| 7,500,000 | |
| 9,601,000 | |
| 101,854,000 | |
| 41,568,000 | |
| 11,449,000 | |
| -10,845,000 | |
| -25,286,000 | |
| -25,119,000 | |
| -34,424,000 | |
| -35,926,000 | |
| -28,988,000 | |
| -26,046,000 | |
| 5,901,000 | |
| 8,003,000 | |
| 10,565,000 | |
| 9,247,000 | |
| -8,797,000 | |
| -8,324,000 | |
| -10,117,000 | |
| -8,531,000 | |
| -6,124,000 | |
| -5,736,000 | |
| -4,996,000 | |
| -2,681,000 | |
| -6,884,000 | |
| -4,256,000 | |
| -309,000 | |
| -2,336,000 | |
| 106,000 | |
| -1,851,000 | |
| 2,256,000 | |
| 7,252,000 | |
| 10,686,000 | |
| 13,888,000 | |
| 9,292,000 | |
| 5,334,000 | |
| 1,552,000 | |
| 77,000 | |
| -277,000 | |
| -337,000 | |
| -804,000 | |
| -239,000 | |
| 138,000 | |
| 1,419,000 | |
| 4,160,000 | |
| 6,719,000 | |
| 6,529,000 | |
| 5,292,000 | |
| 3,723,000 | |
| 124,178,000 | |
| 122,528,000 | |
| 118,494,000 | |
| 115,208,000 | |
| -10,889,000 | |
| 3,104,000 | |
| 3,984,000 | |
| 3,463,000 | |
| 3,332,000 | |
| -56,735,000 | |
| -56,739,000 | |
| -56,745,000 | |
| -61,689,000 | |
| -40,631,000 | |
| -37,998,000 | |
| -35,400,000 | |
| -29,910,000 | |
| -10,470,000 | |
| -10,406,000 | |
| -10,129,000 | |
| -8,363,000 | |
| 718,000 |